Oireachtas Joint and Select Committees
Wednesday, 8 November 2017
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Michael Harty (Clare, Independent) | Oireachtas source
The Deputy may ask a supplementary question later. I must allow other members to contribute. I have another question. What is the manner of engagement with patient groups because such groups feel they are not being engaged with in a meaningful manner? What about representative organisations and specialists in the field where the drug applies, who feel they are not being engaged in a meaningful manner? What is the manner of engagement?
No comments